Blood Now Accounts for 2% of Murica's Exports -- More than Corn or Soya

mintpressnews |  For much of the world, donating blood is purely an act of solidarity; a civic duty that the healthy perform to aid others in need. The idea of being paid for such an action would be considered bizarre. But in the United States, it is big business. Indeed, in today’s wretched economy, where around 130 million Americans admit an inability to pay for basic needs like food, housing or healthcare, buying and selling blood is of the few booming industries America has left. 

The number of collection centers in the United States has more than doubled since 2005 and blood now makes up well over 2 percent of total U.S. exports by value. To put that in perspective, Americans’ blood is now worth more than all exported corn or soy products that cover vast areas of the country’s heartland. The U.S. supplies fully 70 percent of the world’s plasma, mainly because most other countries have banned the practice on ethical and medical grounds. Exports increased by over 13 percent, to $28.6 billion, between 2016 and 2017, and the plasma market is projected to “grow radiantly,” according to one industry report. The majority goes to wealthy European countries; Germany, for example, buys 15 percent of all U.S. blood exports. China and Japan are also key customers.

It is primarily the plasma– a golden liquid that transports proteins and red and white blood cells around the body– that makes it so sought after. Donated blood is crucial in treating medical conditions such as anemia and cancer and is commonly required to perform surgeries. Pregnant women also frequently need transfusions to treat blood loss during childbirth. Like all maturing industries, a few enormous bloodthirsty companies, such as Grifols and CSL, have come to dominate the American market.